Loading institutional data...
Loading institutional data...
Held by 514 of 5,944 reporting institutions (97th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $300K 100.0% | $0 | $0 | — | — | — |
| Cost of Revenue | $200K 66.7% | $0 | $0 | — | — | — |
| Research & Development | $493.9M 164633.3% | $357.7M | $276.4M | $171.5M | $64.3M | $21.1M |
| Selling, General & Admin | — | — | $168.4M | $165.1M | $176.7M | $3.5M |
| Total Operating Expenses | $729.6M 243200.0% | $509.7M | $446.9M | $347.4M | $358.3M | $24.6M |
| Operating Income | -$729.3M -243100.0% | -$509.7M | -$446.9M | -$347.4M | -$358.3M | -$24.6M |
| Interest Expense | — | — | — | — | $1.0M | $200K |
| Other Income (Expense), net | $58.6M 19533.3% | -$48.8M | -$26.9M | $27.8M | $10.6M | $0 |
| Pretax Income | -$617.9M -205966.7% | -$536.6M | -$457.4M | -$317.3M | -$347.8M | -$24.8M |
| Income Tax Expense | $300K 100.0% | $200K | $500K | $0 | $0 | — |
| Net Income | -$618.2M -206066.7% | -$536.8M | -$457.9M | -$317.3M | -$347.8M | -$24.8M |
| Per Share | ||||||
| EPS (Basic) | $-0.99 | $-1.42 | $-1.69 | $-1.32 | $-3.14 | $-0.49 |
| EPS (Diluted) | $-0.99 | $-1.42 | $-1.69 | $-1.32 | $-3.14 | $-0.49 |
| Weighted Avg Shares (Basic) | 624.3M | 376.7M | 270.4M | 240.5M | 110.8M | 50.2M |
| Weighted Avg Shares (Diluted) | 624.3M | 376.7M | 270.4M | 240.5M | 110.8M | 50.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
5/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$512M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 6 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -27%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 6 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $1.0B covers all $81M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~10.8% on $9M of debt. Interest last disclosed in FY2021 (no longer broken out).
Cash of $1.0B fully covers short-term debt of $800000.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
No current price collected.
No standout strengths flagged.
Nothing notable to watch.
Where each multiple sits in its own 6-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 6-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cost of Revenue | — | — | — | — | — | 66.7 |
| R&D | — | — | — | — | — | 164633.3 |
| Operating Income | — | — | — | — | — | -243100.0 |
| Income Tax | — | — | — | — | — | 100.0 |
| Net Income | — | — | — | — | — | -206066.7 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ACHR: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position